Drug Discovery - A human-centric approach for evaluating oligonucleotide delivery and efficacy
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Request a Sample: Research Transfection ReagentsRequest a Sample: Research Transfection Reagents

Sartorius’ range of best-in-class, ready-to-use transfection reagents for life science research allows researchers to study the function of a protein of interest, its role in a signaling pathway, perform genome editing using plasmid-based or RNA-based methods, and conduct cost-effective RNA interference to transfect guide RNA and express Cas9 protein in hard-to-transfect cells.

Request a Sample Here
 
 
    A human-centric approach for evaluating oligonucleotide delivery and efficacyA human-centric approach for evaluating oligonucleotide delivery and efficacy
 
CN Bio’s latest application note demonstrates the effectiveness of the PhysioMimix® oligonucleotide delivery assay for studying liver-targeting oligonucleotide uptake and gene knockdown. Utilizing a predictive human Liver-on-a-chip (or Liver microphysiological system), the assay’s human-relevant insights address current development challenges, bridging the gap between preclinical and clinical studies.
 
Read the App Note
 
 
   How Insects Are Helping Us Make New MedicinesHow Insects Are Helping Us Make New Medicines
 
The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable solutions for medical applications.
 
 ‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancer
 
‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancerA world-first clinical trial launched in Melbourne is being hailed a ‘game-changer’ for its potential to revolutionize the way people with bowel cancer are treated.
 
 
 New Drug Combo Shows Promise Against Aggressive Leukemia in Landmark Study
 
New Drug Combo Shows Promise Against Aggressive Leukemia in Landmark StudyA novel drug combination targeting LSD1 and GSK3 shows promise in treating acute myeloid leukemia by promoting cell differentiation and reducing tumor growth.
 
 
 Experimental cancer drug shows promise in boosting tuberculosis treatment
 
Experimental cancer drug shows promise in boosting tuberculosis treatmentAn experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, based on mouse-model research of the lung-damaging disease.
 
 
 What Pharma Needs to Know About Green Chemistry
 
What Pharma Needs to Know About Green ChemistryThe pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and enhance drug discovery processes.
 
 
    MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.
 

Use this GPT to search for edited and trustworthy references, articles, and equipment reviews from over 20 years of trusted medical and healthcare content.

Currently only available to ChatGPT Plus account holders.


 
Ask a Question Now
 
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025
OSZAR »